(Q34336675)

English

Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

actinic keratosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Aditya K. Gupta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

M Paquet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

0 references

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

169

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

250-259

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23550994%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Management of field change in actinic keratosis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Topical diclofenac/hyaluronic acid gel in the treatment of solar keratoses.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Topical treatment of actinic keratoses with 3.0% diclofenac in 2.5% hyaluronan gel.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Short‐course therapy with imiquimod 5% cream for solar keratoses: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Topical diclofenac in hyaluronan gel for the treatment of solar keratoses

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Imiquimod-induced regression of actinic keratosis is associated with infiltration by T lymphocytes and dendritic cells: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Topical methyl aminolevulinate photodynamic therapy using red light-emitting diode light for multiple actinic keratoses: a randomized study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Ingenol mebutate gel for actinic keratosis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Treatment with 5-aminolaevulinic acid methylester is less painful than treatment with 5-aminolaevulinic acid nanoemulsion in topical photodynamic therapy for actinic keratosis

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Topical photodynamic therapy with porphyrin precursors--assessment of treatment-associated pain in a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Photodynamic therapy of non-melanoma skin cancer with methyl aminolaevulinate is associated with less pain than with aminolaevulinic acid

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

An economic evaluation of topical treatments for actinic keratosis.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study

1 reference

https://api.crossref.org/works/10.1111%2FBJD.12343

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34336675&oldid=1995876074"